ID   ZEC-014
AC   CVCL_VT79
DR   CCRID; 4201PAT-CCTCC00890
DR   Wikidata; Q98136446
RX   Patent=CN106011069A;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201689.
CC   Population: Chinese.
CC   Doubling time: ~22 hours (Patent=CN106011069A).
ST   Source(s): Patent=CN106011069A
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D12S391: 17,23
ST   D13S317: 12
ST   D16S539: 11
ST   D18S51: 15
ST   D19S433: 14
ST   D21S11: 32.2
ST   D2S1338: 24
ST   D3S1358: 16
ST   D5S818: 12
ST   D6S1043: 12
ST   D7S820: 8,13
ST   D8S1179: 12,16
ST   FGA: 26
ST   Penta D: 13
ST   Penta E: 17
ST   TH01: 7,9
ST   TPOX: 11
ST   vWA: 14,17
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 8
//
RX   Patent=CN106011069A;
RA   Su D., Xiong L., Mao W.-M., Jiang Y.-H., Ying L.-S., Xie Z.-H.,
RA   Wu J.-Z.;
RT   "Esophageal cancer cell line and application thereof.";
RL   Patent number CN106011069A, 12-Oct-2016.
//